Teladoc Health, Inc. (TDOC)

NYSE: TDOC · USD

$6.87

+0.42 (+6.5%)· Recorded snapshot

Market cap	1.2B
Revenue (ttm)	2.5B
Net income (ttm)	-177.4M
EPS (ttm)	-$0.99
Shares out	181.7M
Volume	6,314,467
Beta	2.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.5B
Net income (ttm): -177.4M
EPS (ttm): -$0.99
Market cap: 1.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-13

P25 -113.8P50 -46.5P75 -0.9

ROIC-3.8

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All TDOC indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001477449
Company name	Teladoc Health, Inc.
Country	United States
Country code	US
CUSIP number	87918A105
Earnings date	2026-10-28
Earnings time	amc
Employees	5,600
Employees change	100
Employees growth	1.82%
Enterprise value	$1.5B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2002
In index	RUSSELL2000
Industry	Health Information Services
IPO date	2015-07-01
Is primary listing	Yes
Is SPAC	No
ISIN number	US87918A1051
Last 10-K release date	2026-02-26
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.2B
Market cap category	Small-Cap
Next earnings date	2027-02-24
Options	Yes
Price	$6.87
Price currency	USD
Sector	Healthcare
SIC code	8011
Stock price date	2026-10-28
Symbol	TDOC
U.S. state	New York
Website	https://www.teladochealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-14.45%
EV/EBITDA	23.39x
EV/FCF	5.95x
EV/Sales	0.61x
FCF / EV yield	16.8%
FCF yield	20.33%
Forward EV/Sales	0.63x
Forward P/S	0.52x
Industry forward P/E	35.4x
P/(FCF - SBC) ratio	6.34x
P/(OCF - SBC) ratio	6.11x
P/B ratio	0.89x
P/FCF ratio	4.92x
P/OCF ratio	4.78x
P/S ratio	0.5x
Price/EBITDA ratio	19.33x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-5.85%
EBITDA margin	2.59%
FCF margin	10.19%
Gross margin	68.97%
Operating margin	-5.85%
Pretax margin	-7.33%
Profit margin	-7.13%
Profit per employee	$-31,678
Revenue per employee	$444,550
ROA	-3.22%
ROA (5Y)	-2.32%
ROCE	-10.58%
ROE	-12.99%
ROE (5Y)	-45.49%
ROIC	-3.79%
SBC / revenue	2.28%
Tax / revenue	-0.21%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
FCF growth	-13.03%
FCF growth (Q)	-29.31%
FCF growth (QoQ)	711.28%
FCF growth 3Y	3.53%
Gross profit growth	-3.88%
Gross profit growth (Q)	-5.73%
Gross profit growth 3Y	-1.11%
Gross profit growth 5Y	9.41%
Net income growth years	1
OCF growth	-13.92%
OCF growth (Q)	-29.28%
OCF growth (QoQ)	579.51%
OCF growth 3Y	2.45%
Revenue growth	-2.08%
Revenue growth (Q)	-3.95%
Revenue growth (QoQ)	-1.13%
Revenue growth 10Y	38.48%
Revenue growth 3Y	-0.55%
Revenue growth 5Y	8.85%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-7.5M
Depreciation and amortization	$210.2M
EBIT	$-145.7M
EBITDA	$64.6M
EPS	$-0.99
FCF per share	$1.40
Financing cash flow	$-4.1M
Free cash flow	$253.7M
Free cash flow minus SBC	$196.9M
Gross profit	$1.7B
Income taxes	$-5.2M
Investing cash flow	$-161.2M
Net cash flow	$94.7M
Net income	$-177.4M
Operating cash flow minus SBC	$204.4M
Operating income	$-145.7M
Revenue	$2.5B
Stock-based compensation	$56.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-7.25
Book value per share	$7.21
Debt / EBITDA	13.27
Debt / equity	0.79
Debt / FCF	4.08
Goodwill	$283.2M
Interest coverage	-7.3
Long-term assets	$1.6B
Long-term liabilities	$66.8M
Net cash (debt)	$-261.9M
Net cash / market cap	-20.98%
Net debt / EBITDA	4.06
Net debt / equity	0.2
Net debt / FCF	1.03
Piotroski F-Score	3
Property, plant and equipment	$47.4M
Shareholders' equity	$1.3B
Tangible book value	$-148.8M
Tangible book value per share	$-0.82
Total assets	$2.8B
Total cash	$774.3M
Total debt	$1B
Total liabilities	$1.4B
WACC	9.46%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.88
Current assets	$1.1B
Current liabilities	$1.4B
Current ratio	0.83
Inventory turnover	23.07
Net working capital	$-1M
Quick ratio	0.73
Working capital	$-233.4M
Working capital turnover	11.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.97%
Dividend yield	0%
Shareholder yield	-2.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-53.89%
10Y return CAGR	-7.45%
10Y total return	-53.89%
150-day SMA	$6.81
1D price change	6.51%
1M price change	12.81%
1M total return	12.81%
1W price change	9.05%
1W total return	9.05%
1Y price change	-23.75%
1Y return CAGR	-23.77%
1Y total return	-23.75%
20-day SMA	$5.97
200-day SMA	$6.45
3M price change	-22.9%
3M total return	-22.9%
3Y price change	-55.88%
3Y return CAGR	-23.87%
3Y total return	-55.88%
50-day SMA	$6.15
50-day SMA vs 200-day SMA	50under200
52-week high	$9.89
52-week high date	2026-07-16
52-week low	$4.40
52-week low date	2026-02-12
5Y price change	-95.04%
5Y return CAGR	-45.17%
5Y total return	-95.04%
6M price change	17.44%
6M total return	17.44%
All-time high	$308.00
All-time high date	2021-02-16
All-time low	$4.40
All-time low date	2026-02-12
Average true range (ATR)	$0.27
Average volume	3.7M
Beta (1Y)	1.78
Beta (2Y)	1.65
Beta (5Y)	2.14
Change from 52-week high	-30.51%
Change from 52-week low	56.14%
Change from all-time high	-97.77%
Change from all-time low	56.14%
Change from open	7.01%
Day's gap	-0.47%
Dollar volume	$43.4M
High price	$6.87
Low price	$6.42
Monthly RSI	39.96
Open price	$6.42
Position in 52-week range	100%
Premarket change	-1.24%
Premarket close	$6.45
Premarket price	$6.37
Previous close	$6.45
Price vs 150-day SMA	0.88%
Price vs 20-day SMA	15.02%
Price vs 200-day SMA	6.5%
Price vs 50-day SMA	11.71%
Relative volume	1.75
RSI	66.84
Sharpe ratio	-0.2
Sharpe ratio (3Y)	-0.3
Sharpe ratio (5Y)	-0.64
Sortino ratio	-0.19
Sortino ratio (3Y)	-0.33
Sortino ratio (5Y)	-0.8
Volume	6.3M
Weekly RSI	52.53
YTD price change	-1.86%
YTD total return	-1.86%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	180.4M
Float percentage	99.31%
Shares change (QoQ)	1.06%
Shares change (YoY)	2.97%
Shares held by insiders	0.69%
Shares held by institutions	86.58%
Shares outstanding	181.7M
Short % of float	16.68%
Short % of shares	16.57%
Short ratio	8.9 days

Deeper analysis on TDOC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TDOC report

Is a complete TDOC research report available?

No complete published report is available for Teladoc Health, Inc. (TDOC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Teladoc Health, Inc. (TDOC)

Price

Financial snapshot

Fair-value bridge

Latest news · TDOC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TDOC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TDOC

Frequently asked questions